Antiplatelet Drugs Market, By Product Type (Clopidogrel, Aspirin, Prasugrel, Ticagrelor, Cangrelor, Abciximab, Others), By Mode of Administration (Oral, Intravenous), and By Region (North America, Europe, Asia Pacific, Middle East & Africa, South America) – Market Size & Forecasting To 2028

The Global Antiplatelet Drugs Market was valued at USD XX Million in 2020 and is expected to reach USD XX Million by 2028, registering at a CAGR of xx% during the forecast period. Antiplatelet drugs are a group of powerful medicines that prevent blood clots. For effective arterial circulation, the antiplatelet drugs are mainly used. Also for primary and secondary prevention of thrombotic cerebrovascular and cardiovascular disorders these drugs are used. Antiplatelet agents such as dipyridamole, aspirin, clopidogrel, and ticlopidine work by inhibiting the production of thromboxane.

It has been seen that most of time aspirin is highly recommended for preventing a first stroke. In most of the developed countries, people suffering from ischemic strokes have increased a larger scale. Antiplatelet drugs are not used in reducing in blood thinning process. The use of these drugs helps in decreasing the ability of platelets to obstruct and sticks together blood clots formation that leads to these diseases. Thus, the high demand for antiplatelet drugs has grown significantly in the past few years.

As per the American Heart Association, there are approximately 800,000 individuals suffer from stroke each year in the U.S. amid three out of four people experience stroke at the very first time. The patients having heart attacks as maximum number of the attacks are caused due to clots in the arteries that feed the heart muscle for these patients the antiplatelet agents are extensively used. They are also used in patients who undergo surgical procedure such as angioplasty, which is used to unblock an artery through the insertion of a tube called stent.

Clotting of blood is physiological action of the body which helps in regulating external bleeding during the time of injuries. When this blood clots occurs within the blood vessels, it can lead to severe condition because it block the blood flow. Therefore therapeutically the antiplatelet drugs agents are used to stop clotting. Antiplatelet agent normally reduces the clumping of blood cells thereby reducing the potentially harmful blood clots. Antiplatelet agents are given to people, who are at high risk of heart disease.

Some of the impact factors:

  • Development in pharmaceuticals, and increasing thrombolytic events are the major factors driving the antiplatelet drugs market growth.
  • Developing markets and high investment in research and development are the factors will likely drive the growth of the market.
  • Introduction of drugs annually and advancements in treatment are some of the driving factors that fuels the antiplatelet drugs market growth

What does this report provide?

The study report of antiplatelet drugs market offers in-depth overview of the market. It includes information focusing on trends, opportunities, drivers, and restraints affecting the growth of the market. In addition, regional analysis with major sector analysis derived through facts and figures is also included in the antiplatelet drugs market report. The report on the global antiplatelet drugs market includes the competitive landscape, it also offers in-detailed description about the key players in the market. The report provides defined technological growth map with an impact-analysis. It also comprised of individual market changes in regulations and impacting factors in the market domestically that controls the future and current trends of the market.

Market Segmentation:

By Product type:   

  • Aspirin
  • Clopidogrel
  • Prasugrel
  • Ticagrelor
  • Cangrelor
  • Abciximab
  • Others

By Mode of Administration:

  • Oral
  • Intravenous

By Region:

North America Antiplatelet Drugs Market

  • North America, by Country
    • US
    • Canada
    • Mexico
  • North America, by Product type
  • North America, by Mode of Administration

Europe Antiplatelet Drugs Market

  • Europe, by Country
    • Germany
    • Russia
    • UK
    • France
    • Italy
    • Spain
    • The Netherlands
    • Rest of Europe 
  • Europe, by Product type
  • Europe, by Mode of Administration

Asia Pacific Antiplatelet Drugs Market

  • Asia Pacific, by Country
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Indonesia
    • Rest of Asia Pacific 
  • Asia Pacific, by Product type
  • Asia Pacific, by Mode of Administration

Middle East & Africa Antiplatelet Drugs Market

  • Middle East & Africa, by Country 
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of Middle East & Africa
  • Middle East & Africa, by Product type
  • Middle East & Africa, by Mode of Administration

South America Antiplatelet Drugs Market

  • South America, by Country 
    • Brazil
    • Argentina
    • Colombia
    • Rest of South America
  • South America, by Product type
  • South America, by Mode of Administration

Major Companies:  AstraZeneca,  Portola Pharmaceuticals, Inc., The Medicines Company, Bayer Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company,  Altimed Pharma Inc., Alta Laboratories Ltd, Dominion Pharmacal, Novacap, Nanjing Pharmaceutical Factory, Sanis Health Inc, Shandong Xinhua Pharmaceutical, Hoffmann La Roche, Syntex Inc.,  Teva, Pharmascience Inc., Mylan Pharmaceuticals, and Nu Pharm Inc.

Years Covered in the Study:

Historic Year: 2017-2018

Base Year: 2019

Estimated Year: 2020

Forecast Year: 2028

Objectives of this report:

  • To anticipate market size for antiplatelet drugs market on global and regional basis.
  • To classify key sectors in antiplatelet drugs market and evaluate their market demand and shares.
  • To offer a competitive scenario for the antiplatelet drugs market with major developments observed by major companies in the historic years.
  • To evaluate major factors governing the dynamics of market with their possible gravity in the forecast period.

Reasons to Buy This Report:

  • Conveys niche insights for decisions about each potential sector helping in the strategic decision-making process.
  • The antiplatelet drugs market estimation is based on Market size, it is based on a regional and global basis.
  • An exclusive research design for market size estimation and forecast.
  • Identification of key companies working in the market with associated developments
  • Complete scope to cover all the possible sectors helping every stakeholder in the antiplatelet drugs market

Customization:

This study report is customized to meet your detailed requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country
  • Product Specific Competitive Analysis

For more information, contact: sales@quincemarketinsights.com